Eli Lilly completed the acquisition of Pleasant Prairie facility from Nexus Pharmaceuticals.

Eli Lilly, a medicine company, completed the acquisition of Pleasant Prairie facility from Nexus Pharmaceuticals, a pharmaceutical company. Financial terms were not disclosed. “The acquisition of this state-of-the-art facility underscores our unwavering commitment to growth and innovation, and we look forward to welcoming talented new Nexus colleagues to Lilly from the Pleasant Prairie facility. We are investing boldly to serve our patients, to meet product demand and to build capabilities for our robust pipeline of the future,” Edgardo Hernandez, Eli Lilly Manufacturing Executive Vice President and President.